Repository logo
  • English
  • Deutsch
  • Español
  • Français
  • Log In
    New user? Click here to register.Have you forgotten your password?

  • English
  • Deutsch
  • Español
  • Français
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • Research Outputs
  • Fundings & Projects
  • Researchers
  • Statistics
  1. Home
  2. Current Research Information System UV
  3. Publicaciones
  4. Effects Of Interleukin-1 Beta In Glycinergic Transmission At The Central Amygdala
 
  • Details
Options

Effects Of Interleukin-1 Beta In Glycinergic Transmission At The Central Amygdala

Date Issued
2021-03-05
Author(s)
Castillo, Karen  
Facultad de Ciencias  
Jocelyn Solorza
Carolina A. Oliva
Gabriela Amestica
María C. Maldifassi
Xaviera A. López-Cortés
Rafael Barra
Jimmy Stehberg
Matthias Piesche
Patricio Sáez‐Briones
Wendy González
Mauricio Arenas‐Salinas
Trinidad Mariqueo
DOI
10.3389/fphar.2021.613105
WoS ID
WOS:000630340400001
Abstract
Interleukin-1β (IL-1β) is an important cytokine that modulates peripheral and central pain sensitization at the spinal level. Among its effects, it increases spinal cord excitability by reducing inhibitory Glycinergic and GABAergic neurotransmission. In the brain, IL-1β is released by glial cells in regions associated with pain processing during neuropathic pain. It also has important roles in neuroinflammation and in regulating NMDA receptor activity required for learning and memory. The modulation of glycine-mediated inhibitory activity via IL-1β may play a critical role in the perception of different levels of pain. The central nucleus of the amygdala (CeA) participates in receiving and processing pain information. Interestingly, this nucleus is enriched in the regulatory auxiliary glycine receptor (GlyR) β subunit (βGlyR); however, no studies have evaluated the effect of IL-1β on glycinergic neurotransmission in the brain. Hence, we hypothesized that IL-1β may modulate GlyR-mediated inhibitory activity via interactions with the βGlyR subunit. Our results show that the application of IL-1β (10 ng/ml) to CeA brain slices has a biphasic effect; transiently increases and then reduces sIPSC amplitude of CeA glycinergic currents. Additionally, we performed molecular docking, site-directed mutagenesis, and whole-cell voltage-clamp electrophysiological experiments in HEK cells transfected with GlyRs containing different GlyR subunits. These data indicate that IL-1β modulates GlyR activity by establishing hydrogen bonds with at least one key amino acid residue located in the back of the loop C at the ECD domain of the βGlyR subunit. The present results suggest that IL-1β in the CeA controls glycinergic neurotransmission, possibly via interactions with the βGlyR subunit. This effect could be relevant for understanding how IL-1β released by glia modulates central processing of pain, learning and memory, and is involved in neuroinflammation.
Subjects

Pharmacology And Phar...

Pharmacology

OCDE Subjects

Medical And Health Sc...

Quartile (Date Issued)
Q1
License
acceso abierto
Open Science Path
https://creativecommons.org/licenses/by/4.0/
Product(s)
datasheet1_Effects of Interleukin-1β in Glycinergic Transmission at the Central Amygdala.pdf  

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback

Hosting & Support by

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science